NX-13 Catalog No.:M15889-10 2-dihydropyridin-3-yl)carbamoyl]-6-[(1-methyl-1H-imidazol-5-yl)formamido]hex-2-enoate

2-dihydropyridin-3-yl)carbamoyl]-6-[(1-methyl-1H-imidazol-5-yl)formamido]hex-2-enoate

(E)-Ferulic acid methyl ester (Methyl (E)-ferulate) exhibits strong DPPH and ABTS+ radical scavenging activities

Chemical Name: 3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid

and inhibits the proliferation and PGE(2) production by fibroblast-like synovial cells (FLS)

InChiKey: BMGQWWVMWDBQGC-AKZXJVOYSA-N

NX-13 Catalog No.:M15889-10 2-dihydropyridin-3-yl)carbamoyl]-6-[(1-methyl-1H-imidazol-5-yl)formamido]hex-2-enoateNX 13 is a first in class, orally active and gut restricted agent that selectively targets and activates the NLRX1 pathway to induce immunometabolic changes. NX 13 results in lower inflammation and responses in inflammatory bowel disease. NX 13 can be used for the research of crohn's disease and ulcerative colitis. Product information CAS Number: 2389235 01 0 Molecular Weight: 399. 44 Formula: C24H21N3O3 Chemical Name: 2 {3, 5 bis[(6 methylpyridin 2